Shilpa Pharma Lifesciences Awarded EcoVadis Gold Medal for Outstanding Sustainability Practices

EcoVadis assesses organizations on four key pillars — Environment, Labor & Human Rights, Ethics, and Sustainable Procurement — and this recognition positions Shilpa Pharma Lifesciences among the top few global companies rated for sustainable business operations. EcoVadis assesses organizations on four key pillars — Environment, Labor & Human Rights, Ethics, and Sustainable Procurement — and this recognition positions Shilpa Pharma Lifesciences among the top few global companies rated for...
Comunicato Precedente

next
Comunicato Successivo

next
India, (informazione.news - comunicati stampa - salute e benessere)

EcoVadis assesses organizations on four key pillars — Environment, Labor & Human Rights, Ethics, and Sustainable Procurement — and this recognition positions Shilpa Pharma Lifesciences among the top few global companies rated for sustainable business operations.

Speaking on this milestone, Mr. Keshav Bhutada, ED & CEO of Shilpa Pharma Lifesciences emphasized that "Sustainability and innovation are integral to Shilpa's CDMO growth strategy to work with global innovator companies for their New chemical Entity programs. The EcoVadis Gold Medal is a testimony to our relentless efforts toward responsible manufacturing, ethical governance, and inclusive growth that creates enduring value for patients and partners. We look forward to work with more global innovator companies"

This achievement further strengthens Shilpa's credentials with global customers, investors, and partners, reinforcing their positioning as a trusted global CDMO partner with sustainability at the core of their operations.

About Shilpa Medicare Limited

Shilpa Pharma Lifesciences Awarded EcoVadis Gold Medal for Outstanding Sustainability Practices

Shilpa Medicare Limited (BSE: 530549 | NSE: SHILPAMED) is a leading Indian pharmaceutical company focused on the development, manufacture, and marketing of APIs, formulations, and biologics across oncology, infectious diseases, and specialty segments. With expertise in complex generics, novel drug delivery systems, and CDMO services, Shilpa serves patients in over 80 countries. For more information, visit www.vbshilpa.com

Forward-Looking Statement Disclaimer

This document contains forward-looking statements describing the Company's objectives, plans, and expectations for future performance. Actual results may differ materially due to risks and uncertainties including regulatory approvals, clinical outcomes, market conditions, and competitive developments. Shilpa Medicare undertakes no obligation to update forward-looking statements to reflect subsequent events or circumstances.

Logo - https://mma.prnewswire.com/media/2489785/Shilpa_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/shilpa-pharma-lifesciences-awarded-ecovadis-gold-medal-for-outstanding-sustainability-practices-302610563.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;